As Daniel Bohsen , Novo Nordisks Senior Vice President of Finance Operations, explained, the company has been active in obesity care for more than two decades , and emphasized, Rather than focusing on market share, our efforts are to expand the market, including serving the oral segment within anti-obesity medicine. In parallel, Novo is integrating artificial intelligence into its research pipeline through a partnership with Nvidia and the Danish Center for AI Innovation
But recent research* presented at ENDO 2025 has revealed something concerning about these medications that most doctors aren't discussing with their patients
Cognitive support in older adults: Some early clinical research has explored acetyl-L-carnitine in the context of age-related cognitive changes, including studies conducted in populations with diagnosed cognitive conditions (Rai, et al., 1990) and general age-related cognitive decline (Passeri, et al., 1988)
It reversed TBI-induced loss of dendritic density and synaptic connections